Biovica International AB (publ) (FRA:9II)

Germany · Delayed Price · Currency is EUR

0.0054

-0.0002 (-3.57%)

Last updated: Feb 23, 2026, 8:21 AM CET

Revenue by Segment

Financials in millions SEK. Fiscal year is May - April.

Millions SEK. Fiscal year is May - Apr.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021	Apr '20 Apr 30, 2020	Apr '19 Apr 30, 2019	Apr '18 Apr 30, 2018	Apr '17 Apr 30, 2017	Apr '16 Apr 30, 2016
Biotechnology	8.65M	7.30M	5.21M	5.10M	7.48M
Biotechnology Growth	18.53%	39.99%	2.22%	-31.84%	-22.71%
Total	8.65M	7.30M	5.21M	5.10M	7.48M
Total Growth	18.53%	39.99%	2.22%	-31.84%	-22.71%

Revenue by Geography

Financials in millions SEK. Fiscal year is May - April.

Millions SEK. Fiscal year is May - Apr.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021	Apr '20 Apr 30, 2020	Apr '19 Apr 30, 2019	Apr '18 Apr 30, 2018	Apr '17 Apr 30, 2017	Apr '16 Apr 30, 2016
Sweden	-	41.00K	-	-	299.00K
EU Excl. Sweden	531.00K	1.37M	125.00K	102.00K	531.00K
EU Excl. Sweden Growth	-61.21%	995.20%	22.55%	-80.79%	33.75%
Rest of The World	536.00K	297.00K	-	-	-
Rest of The World Growth	80.47%	-	-	-	-
USA	7.55M	5.58M	3.26M	1.94M	1.25M
USA Growth	35.27%	71.36%	67.68%	55.81%	-0.16%
Total	8.62M	7.29M	3.38M	2.05M	2.08M
Total Growth	18.23%	115.49%	65.43%	-1.54%	24.30%

Source: S&P Global Market Intelligence.